Nath Bio-Genes (India) Limited

NSEI:NATHBIOGEN Rapporto sulle azioni

Cap. di mercato: ₹3.3b

Nath Bio-Genes (India) Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Satish Kagliwal

Amministratore delegato

₹6.6m

Compenso totale

Percentuale dello stipendio del CEO100.0%
Mandato del CEO25.3yrs
Proprietà del CEOn/a
Durata media del management6.3yrs
Durata media del Consiglio di amministrazione4yrs

Aggiornamenti recenti sulla gestione

Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely

Aug 11
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely

Recent updates

Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely

Aug 11
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely

Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations

Jul 31
Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth

Jul 02
Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth

These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well

Jun 27
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well

Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward

Apr 05
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward

Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes

Oct 24
Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes

Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly

Aug 05
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly

Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger

Jun 07
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger

Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital

Feb 11
Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital

We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt

Aug 27
We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt

Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business

Jun 19
Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business

Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet

Feb 24
Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet

Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)

May 27
Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)

Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?

Feb 28
Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?

The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About

Feb 07
The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About

Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?

Jan 19
Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?

The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It

Jan 01
The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It

Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters

Dec 14
Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters

These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well

Nov 26
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well

Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital

Nov 05
Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital

Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?

Oct 15
Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%

Sep 24
Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%

Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Sep 08
Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years

Sep 07
Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares

Aug 18
Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares

Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay

Jul 26
Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Satish Kagliwal rispetto agli utili di Nath Bio-Genes (India)?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

₹394m

Jun 30 2024n/an/a

₹398m

Mar 31 2024₹7m₹7m

₹396m

Dec 31 2023n/an/a

₹374m

Sep 30 2023n/an/a

₹379m

Jun 30 2023n/an/a

₹374m

Mar 31 2023₹5m₹5m

₹350m

Dec 31 2022n/an/a

-₹827m

Sep 30 2022n/an/a

-₹813m

Jun 30 2022n/an/a

-₹815m

Mar 31 2022₹5m₹5m

-₹674m

Dec 31 2021n/an/a

₹561m

Sep 30 2021n/an/a

₹575m

Jun 30 2021n/an/a

₹593m

Mar 31 2021₹5m₹5m

₹557m

Dec 31 2020n/an/a

₹562m

Sep 30 2020n/an/a

₹558m

Jun 30 2020n/an/a

₹565m

Mar 31 2020₹5m₹5m

₹505m

Dec 31 2019n/an/a

₹482m

Sep 30 2019n/an/a

₹478m

Jun 30 2019n/an/a

₹477m

Mar 31 2019₹5m₹5m

₹384m

Dec 31 2018n/an/a

₹349m

Sep 30 2018n/an/a

₹353m

Jun 30 2018n/an/a

₹353m

Mar 31 2018₹3m₹3m

₹294m

Compensazione vs Mercato: La retribuzione totale di Satish ($USD 78.30K ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 42.63K ).

Compensazione vs guadagni: La retribuzione di Satish è aumentata di oltre il 20% nell'ultimo anno.


AMMINISTRATORE DELEGATO

Satish Kagliwal (67 yo)

25.3yrs

Mandato

₹6,600,000

Compensazione

Mr. Satish Kagliwal serves as the Chairman of the Board at Agri-tech (India) Limited and has been its Executive Director since August 30, 1999 & serves as it's Managing Director of Agri-tech (India) Limite...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Satish Kagliwal
MD & Executive Directorno data₹6.60mNessun dato
Dhiraj Rathi
Company Secretary & Compliance Officer6.3yrs₹844.00kNessun dato
Harish Pandey
Vice President of Marketingno data₹7.99mNessun dato
Jeevanlata Kagliwal
Executive Directorno data₹20.00k0.0015%
₹ 50.8k
Abhinay Jadhav
Chief People Officerno data₹4.14mNessun dato
Venkatesh Kulkarni
Vice President of R&D6.4yrs₹10.07mNessun dato
Amol Gupta
Chief Financial Officerless than a yearNessun datoNessun dato

6.3yrs

Durata media

58yo

Età media

Gestione esperta: Il team dirigenziale di NATHBIOGEN è esperto e expertise (durata media dell'incarico 6.3 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Satish Kagliwal
MD & Executive Director25.3yrs₹6.60mNessun dato
Jeevanlata Kagliwal
Executive Director5.5yrs₹20.00k0.0015%
₹ 50.8k
Akash Kagliwal
Non-Executive Director1.6yrs₹15.00kNessun dato
Hitesh Purohit
Independent Non-Executive Director2.7yrs₹20.00kNessun dato
Ashu Jain
Independent Non-Executive Director4.1yrs₹20.00kNessun dato
Vadla Nagabhushanam
Independent Non-Executive Director4yrs₹23.00kNessun dato
Madhukar Deshpande
Independent Non-Executive Director3.8yrs₹23.00kNessun dato

4.0yrs

Durata media

64yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di NATHBIOGEN sono considerati esperti (durata media dell'incarico 4 anni).